Stock Price Updates, Latest Financial Results, and Pending Acquisitions - Research Report on McKesson, Cardinal Health, Rite Aid, Patterson Companies, and Henry Schein

NEW YORK, November 27, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting McKesson Corporation (NYSE: MCK), Cardinal Health, Inc. (NYSE: CAH), Rite Aid Corp. (NYSE: RAD), Patterson Companies Inc. (NASDAQ: PDCO) and Henry Schein, Inc. (NASDAQ: HSIC). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

McKesson Corporation Research Report

On November 22, 2013, McKesson Corporation's (McKesson) stock increased 1.68%, ending the day at $163.61. Over the previous three trading sessions, shares of McKesson increased 2.76% compared to the Dow Jones Industrial Average which also increased 0.61% during the same period. The Full Research Report on McKesson Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/a057_MCK

Cardinal Health, Inc. Research Report

On November 22, 2013, Cardinal Health, Inc.'s (Cardinal Health) stock decreased 0.50%, ending the day at $65.02. Over the previous three trading sessions, shares of Cardinal Health increased 0.12% compared to the Dow Jones Industrial Average which also increased 0.61% during the same period. The Full Research Report on Cardinal Health, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/ee30_CAH

Rite Aid Corp. Research Report

On November 22, 2013, Rite Aid Corp.'s (Rite Aid) stock increased 2.27%, ending the day at $5.40. Over the previous three trading sessions, shares of Rite Aid increased 6.51% compared with the Dow Jones Industrial Average which also increased 0.61%. The Full Research Report on Rite Aid Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/f64e_RAD

Patterson Companies Inc. Research Report

On November 21, 2013, Patterson Companies Inc. (Patterson Companies) reported its Q2 FY 2014 financial results (period ended October 26, 2013). The Company reported consolidated sales of $998.8 million, up 15.2% YoY. During the quarter, net income was $48.7 million, or $0.48 per diluted share (excluding costs regarding the Medical unit restructuring), up from net income of $45.5 million, or $0.44 per diluted share, in Q2 FY 2013. The Company informed that its Q2 FY 2014 results included $117.7 million of consolidated sales and an EPS contribution of $0.01 per diluted share from the acquisition of NVS that closed on August 16, 2013. Scott P. Anderson, Patterson Companies Chairman and CEO, commented, "Patterson Dental is well known for providing customers with industry-leading technology wrapped by a suite of value-added services. This approach helped generate improved second quarter results in our dental business. We expect year-over-year sales growth for our dental business in the second half of the year, which is when the majority of our equipment sales tend to occur." The Full Research Report on Patterson Companies Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/1908_PDCO

Henry Schein, Inc. Research Report

On November 14, 2013, Henry Schein, Inc. (Henry Schein) announced that it has entered into a definitive agreement to acquire an 80% ownership position in privately-held Medivet S.A., a leading distributor of animal health products and services in Poland. Henry Schein predicts that the transaction will be dilutive to its earnings per share by an estimated $0.01 in its initial year and accretive by $0.01-$0.02 in the following year. Subject to approval by Poland's competition and tax authorities, the transaction is slated to close in Q1 2014. Stanley M. Bergman, Chairman of the Board and CEO of Henry Schein, commented, "We are delighted to enter the Polish animal health market in a position of leadership and look forward to welcoming Medivet's highly regarded founder, Piotr Trojanek, and his colleagues to Henry Schein. With this expanded geographic reach, we anticipate providing additional value to our supplier partners while ensuring Medivet's customers have access to the widest array of supplies and value-added products for operating efficient and profitable businesses while delivering high-quality care." Piotr Trojanek, Chairman of Medivet's Supervisory Board, added, "Henry Schein's superior track record for serving animal health practitioners has been demonstrated across Europe, North America and Australasia. Henry Schein has a clear commitment to set the standard for excellence in meeting the practice needs of veterinarians, and we look forward to drawing on these impressive global resources to build on the firm foundation that Medivet has built here in Poland." The Full Research Report on Henry Schein, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/7f38_HSIC

EDITOR NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
5. For any urgent concerns or inquiries, please contact us at [email protected].
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

www.AnalystsCorner.com

SOURCE Analysts' Corner